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is also confusing, likely due at least in part
to the use of cells from different species,
from different hematopoietic compart-
ments, from different stages of ontogeny,
and expressing the TEL-AML1 gene
under the control of different regulatory
elements, none of which used the endog-
enous TEL promoter. The novel aspect of
the present study from the Hock labora-
tory (Schindler et al., 2009) is the adoption
of a genetic engineering strategy that
does employ the endogenous TEL
promoter, in addition to the use of
different strategies that allowed targeting
the expression of TEL-AML1 to hemato-
poietic stem cells and hence all their
derivatives. Examination of the hemato-
poietic system of conditionally targeted
mice (using Mx-Cre activated by polyIC
injection) revealed the stem cell and
myeloid progenitor compartments to
be significantly expanded, although the
output of mature myeloid cells was
not enhanced, and lymphopoiesis was
consistently and selectively compro-
mised from an early stage.
Interestingly, after the mice were
treated with a potent but nonspecific
mutagen (ENU), leukemogenesis was
markedly accelerated and enhanced
in the TEL-AML1 mice as compared to
their normal counterparts. This finding
suggests that the model may recapitulate
the presumed multistep features of TEL-
AML1 ALL pathogenesis in children
(Figure 1). At the same time, the model is
clearly not yet ideal, in that the diseases
obtained in the mice were primarily T-
lineage leukemias rather than B-lineage
leukemias, the latter being the type that
appears exclusively in human cells that
have acquired the TEL-AML1 gene.
Further studies will clearly be needed to
determine the underlying explanation for
this difference and its significance. Possi-
bilities include peculiarities associated
with the experimental use of ENU to
initiate a second ‘‘hit,’’ innate differences
in the early stages of murine and human
lymphopoiesis, and the need to use
embryonic or neonatal mice for induction
of the second hit. Recent data indicate
that the lineage preferences of stem
cells change dramatically during early
life (Dykstra et al., 2007), and hence closer
attention to the ontological status of
the ultimately targeted cell may prove
to be a more important variable than
anticipated.
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Stem cells age, but the underlying mechanisms remain unclear. In a recent issue of Cell, Inomata and
colleagues (2009) show that DNA damage, a prime suspect in stem cell aging, causes graying and loss of
melanocyte stem cells by inducing premature differentiation, without inducing apoptosis or senescence.Agingcanbedescribedasamultisystemic
problem impairing overall fitness. As hu-
mans age, wounds heal more slowly, hair
grays, muscle strength diminishes, and
certain aspects of neurological function
decline. Changes in tissue function with
aging suggested that the aging problem
may lie, in part, with multipotent stem
cells, which have been identified in many
adult tissues, including blood, brain, mu-6 Cell Stem Cell 5, July 2, 2009 ª2009 Elsevscle, skin, intestine, and gonads (Morrison
and Spradling, 2008). Adult tissue stem
cells fuel the renewal of many tissues
through the regulated generation of in-
creasingly committed progenitor cells and
ultimately terminally differentiated cells
that execute specific aspects of tissue
function.However, how somatic stemcells
change with aging is only beginning to be
understood.ier Inc.Reduced regenerative capacity might
suggest that tissue stem cells diminish in
number with advancing age; however,
this trend is not universally the case.
Neural progenitors show diminished num-
bers and impaired proliferative potential
with aging. Melanocyte stem cells, which
give rise to differentiated melanocytes
within the hair follicle, are significantly
depleted in number with aging and in
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(Nishimuraet al., 2005).However,
the abundance of phenotypically
defined hematopoietic stem cells
(HSCs) in mice paradoxically in-
creases with advancing age.
HSC function does diminish with
age, but aging HSCs also show
a skewed maturation toward
myeloid cell fates and away from
lymphoid lineages (Figure 1;
Rossi et al., 2005). Muscle stem
cells, or satellite cells, demon-
stratea reducedcapacity torepair
damaged muscle in aging mice.
Whereas the defects in HSCs
are cell autonomous and can be
demonstrated in young recipient
mice through transplantation,
the defects in satellite cell func-
tion are due to alterations in the
niche and can be reversed
through restoration of a youthful
extracellular environment in para-
biosisexperiments (Conboyetal.,
2005). Thus, reduced stem cell
number, impaired function, and
skewed lineage commitment are
all attributes of aging stem cells,
and these can vary according to
tissue.
What accounts for these
changes in tissue stem cells
with advancing age? There is
increasing evidence that accu-
mulating DNA damage may
be a contributing culprit. Several
human conditions with features
resembling premature aging,
including xeroderma pigmento-
sum, Cockayne syndrome,
trichothiodystrophy, and XPF-
ERCC1 progeria, are caused by
defects in DNA damage repair (Garinis
et al., 2008). The DNA damage response
at shortened telomeres has been impli-
cated in aging and in stem cell dysfunction
(Sharpless and DePinho, 2007). Further-
more, genetically engineered mice with
mutations in DNA repair mechanisms ex-
hibit accelerated aging phenotypes and
specifically show defects in HSC function.
This mechanism appears relevant even
in normal aging because aged wild-type
mice were shown to have much higher
levels of DNA damage foci in purified
HSC than their younger counterparts
(Rossi et al., 2007). Thus, genotoxic stress
may contribute to stem cell dysfunction in
aging, particularly in tissues where the
stem cell defects are cell autonomous.
In their recent Cell paper, Inomata and
colleagues address important questions
concerning the fate of aging tissue stem
cells by analyzing the mechanisms by
which melanocyte stem cells are lost in
the setting of DNA damage (Inomata
et al., 2009). Genotoxic stress has long
been known to cause hair graying, one of
the most visually striking phenotypic
aspects of aging. Melanocyte stem cells
(MSCs) were recently defined using a
mouse reporter strain expressing the lacZ
gene under control of the dopachrome
tautomerase gene (Dct). Dct-lacZ+ MSCs
were found to be located in the
bulge region of the hair follicle,
a niche shared with the multipo-
tent epidermal stem cells. Quies-
cent MSCs give rise to prolifera-
tive transient amplifying cells,
and both of these progenitors
lack melanin pigment. Terminally
differentiated melanocytes ex-
press melanin and are localized
in the lower part of the hair follicle,
and their principal mission is to
transfer melanin pigment to
neighboring keratinocytes, which
comprise the growing hair. In hair
graying, melanin hair pigment is
greatly reduced, and in many
cases, this defect occurs at the
level of theMSC. Incertainmouse
models of graying, MSCs are
diminished, and graying is asso-
ciated with the appearance of
ectopically pigmented melano-
cytes (EPMs) within the stem cell
niche. These EPMs have also
been demonstrated in the niche
in graying human hair follicles
(Nishimura et al., 2005).
An alternative mechanism for
hair graying has been proposed
based on oxidative damage to
pigmented melanocytes, a pro-
cess caused by the toxic by-
products of melanin synthesis
itself (Johnson and Jackson,
1992). The link between oxida-
tive damage and DNA damage
makes it unclear whether the
graying effects of ionizing radia-
tion and other DNA-damaging
agents occur through an effect
on MSCs or on more differenti-
atedmelanocytes. In their current
study, Inomata and colleagues definitively
address thisquestionandshowthatMSCs
are rapidly lost after ionizing radiation.
Concomitant with loss of MSCs, they find
the appearance of EPMs within the niche,
which implies that the MSCs respond to
DNA damage by aberrantly differentiating
within the niche. Through a poorly under-
stood mechanism, DNA damage in the
MSCs presumably overrides cues within
the niche that prevent local differentiation
of the stem cells. Following ionizing radia-
tion, EPMs appear in themiddle of the first
anagen, or growth phase, and are cleared
later in anagen. MSCs completely disap-
pear from the next hair cycle, and the
Figure 1. Altered Differentiation in Aging Tissue Stem Cells
Stem cells exhibit a loss of self-renewal and altered differentiation with
aging. Hematopoietic stem cells skew toward the myeloid lineage at
the expense of lymphoid progenitors during aging in mice. Muscle
stem cells tend toward a fibrogenic fate, which may explain the
increased fibrosis in aging muscles. Melanocyte stem cells are lost
during aging and in response to ionizing radiation. Depletion of mela-
nocyte stem cells correlates with the appearance of ectopically pig-
mented melanocytes within the hair follicle bulge region, the niche
for melanocyte stem cells. Thus, loss of self-renewal leads to rapid
differentiation of melanocyte stem cells within the stem cell niche.Cell Stem Cell 5, July 2, 2009 ª2009 Elsevier Inc. 7
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Consistent with an effect of genotoxic
stress on the MSCs, mice with a mutation
in the DNA damage checkpoint kinase
ATM (mutated in ataxia-telangiectasia)
showed graying at a lower dose of ionizing
radiation and a significant increase in the
appearance of EPMs within the niche.
A particularly striking finding in the
study is that, despite these profound
effects of DNA damage on MSCs, the
authors find no evidence of apoptosis or
senescence in these failing stem cells.
To address this question further, they irra-
diated mice deficient in p53 or deficient in
the INK4A/ARF locus encoding both the
CDK inhibitor p16 and the p53 regulator
p19ARF. Both p53 and INK4A/ARF
have been clearly linked to the cellular
response to DNA damage, to organismal
aging, and to stem cell aging (Sharpless
andDePinho, 2007). The INK4A/ARF locus
is one of the critical targets of the poly-
combproteinbmi-1,which inhibitsexpres-
sion of INK4A/ARF. Loss of bmi-1 dramat-
ically impairs stem cell self-renewal in part
through the derepression of p16 and
p19ARF. Surprisingly, deletion of p53 or
INK4A/ARF had no effect on hair graying
induced by ionization radiation. Similarly,
depletion of MSCs and the appearance
of EPMs within the niche were not depen-Sleuthing the Sour
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Mesenchymal stem cells (MSCs) ca
inflammation. In this issue of Cell St
mation inhibitor TSG-6 by MSCs.
Cellular therapy is a promising field, but
cells tend to be more complicated than
single therapeutic molecules, considering
their source of isolation, ex vivo expan-
sion, their proper handling and delivery,
the potential clinical outcome(s), and their
subsequent evaluation. In this regard,
some have suggested that cells are not
8 Cell Stem Cell 5, July 2, 2009 ª2009 Elsevdent on p53 or INK4A/ARF. Instead, geno-
toxic stress triggers rapid differentiation of
quiescent MSCs through a process that
does not require these common check-
points.
These findings in MSCs are perhaps
related, in part, to those in aging HSCs
and in muscle stem cells (Figure 1). The
altered cell fate of aging HSCs toward
the myeloid lineage (Rossi et al., 2005)
and the aberrant differentiation of muscle
stem cells toward fibrogenic fates (Brack
et al., 2007) may also reflect a subtler
process by which aging or genotoxic
stress influences cell fate in many tissue
stem cell populations. In the case of irradi-
ated MSCs, DNA damage triggers a rapid
and complete loss of self-renewal, result-
ing in local differentiation within the niche.
In other stem cell populations, these alter-
ations in self-renewal or differentiation
with aging may be caused by accumu-
lated DNA damage, altered signaling,
epigenetic changes, or other stimuli. It
will be important to determine whether
this type of differentiation within the niche
seen in MSCs is also a feature of other
stem cells in settings of advancing age
or in response to genotoxic stress. The
findings of Inomata and colleagues su-
ggest that strategies that interfere with
this loss of self-renewal may delay stemce of Regeneratio
Rolling Road, Baltimore, MD 21227, USA
n differentiate into useful cell types an
em Cell, Lee et al. (2009) investigate th
amenable to development as therapeu-
tics, but rather, they will help us to identify
factors to pursue as drugs. Another view
is that cells hold great promise as thera-
peutic agents, as a source for identifying
‘‘druggable’’ factors, and as a manipulat-
able platform for understanding biologics
and medicine. Therefore, continuing to
ier Inc.cell aging and help to preserve tissue
function in the face of genotoxic stress
encountered by stem cells.
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d also have the ability to modulate
e production of the soluble inflam-
evaluate cells for therapeutic potential is
essential. MSCs (mesenchymal stem
cells/multipotent stromal cells) are one
of the current cell types being studied in
many labs as a therapeutic, as a source
of factors to improve tissue repair, and
as a paradigm for many aspects of cell-
cell interaction during tissue repair. One
